COVID-19: A wake-up call to rebalance the drug supply chain?
Wednesday, April 29, 2020 - 10:20
in Mathematics & Economics
Over 80% of chemicals used to make pharmaceuticals sold in Europe originate from China or India, according to the European Fine Chemicals Group. When COVID-19 emerged in Wuhan and spread across the globe, experts worried about disruption of the drug supply chain. Now, nations are rethinking their dependence on other countries for pharmaceutical ingredients and finished drugs, according to an article in Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society.